Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population
Pierre‐Jean Saulnier(Inserm), SURDIAGENE Study group(Inserm), Lise Bankir(Centre National de la Recherche Scientifique), Vincent Rigalleau(Université de Bordeaux), Elise Gand(Université de Poitiers), Samy Hadjadj(Université de Poitiers), Frédéric Fumeron(Inserm), R. Maréchaud(Centre Hospitalier Universitaire de Poitiers), Ronan Roussel(Lyon 1 Université), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), X. Piguel(Centre Hospitalier Universitaire de Poitiers), Stéphanie Ragot(Université de Tours)
Cited by 16
Related Papers
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
|The Lancet Diabetes & Endocrinology|2017|295
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
|The Lancet|2003|286
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228